HomeCompareRENB vs EPRT

RENB vs EPRT: Dividend Comparison 2026

RENB yields 140.85% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RENB wins by $18.16M in total portfolio value
10 years
RENB
RENB
● Live price
140.85%
Share price
$1.42
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.23M
Annual income
$7,605,007.88
Full RENB calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — RENB vs EPRT

📍 RENB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRENBEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RENB + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RENB pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RENB
Annual income on $10K today (after 15% tax)
$11,971.83/yr
After 10yr DRIP, annual income (after tax)
$6,464,256.70/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, RENB beats the other by $6,453,342.08/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RENB + EPRT for your $10,000?

RENB: 50%EPRT: 50%
100% EPRT50/50100% RENB
Portfolio after 10yr
$9.15M
Annual income
$3,808,924.30/yr
Blended yield
41.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

RENB
No analyst data
Altman Z
-174.5
Piotroski
3/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RENB buys
0
EPRT buys
0
No recent congressional trades found for RENB or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRENBEPRT
Forward yield140.85%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$18.23M$63.4K
Annual income after 10y$7,605,007.88$12,840.73
Total dividends collected$16.79M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: RENB vs EPRT ($10,000, DRIP)

YearRENB PortfolioRENB Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$24,785$14,084.51$11,205$505.18+$13.6KRENB
2$59,143$32,624.07$12,672$682.46+$46.5KRENB
3$136,042$72,758.05$14,490$930.48+$121.6KRENB
4$301,974$156,409.10$16,786$1,282.69+$285.2KRENB
5$647,582$324,470.73$19,753$1,791.56+$627.8KRENB
6$1,343,219$650,306.15$23,677$2,541.64+$1.32MRENB
7$2,697,870$1,260,625.08$29,008$3,672.99+$2.67MRENB
8$5,253,056$2,366,334.87$36,463$5,425.08+$5.22MRENB
9$9,926,863$4,306,093.23$47,238$8,221.57+$9.88MRENB
10$18,226,751$7,605,007.88$63,385$12,840.73+$18.16MRENB

RENB vs EPRT: Complete Analysis 2026

RENBStock

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Full RENB Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this RENB vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RENB vs SCHDRENB vs JEPIRENB vs ORENB vs KORENB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.